Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Musculoskeletal | Immunology | Family Medicine
Disease Category: Osteoarthritis
Location: United States, FL

Clinical Trial Details

Overview

Research Study Summary

Clinical Trial to evaluate the effectiveness of investigational medication for the treatment of Osteoarthritis and Rheumatoid Arthritis.

Purpose

Phase IV,Double-Blind, Parallel-Group study of Cardiovascular safety in Osteoarthritis or Rheumatoid Arthritis Patients with or at High Risk for Cardiovascular Disease comparing Celecoxib with Naproxen and Ibuprofen

Patient Inclusion Criteria

  • Men or Women 18 yrs or older
  • Diagnosis of Osteoarthritis or Rheumatoid Arthritis of at least 6 months
  • Must be eligible for chronic daily therapy with an NSAID to control symptoms
  • Subject with established or at high risk for Cardiovascular Disease

Patient Exclusion Criteria

  • Has acute joint trauma with symptoms
  • Planned surgery or invasive procedure
  • Known hypersensitivity to celecoxib, ibuprofen, naproxen, aspirin, esomeprazole, sulfonamides, proton pump inhibitors, lactose or NSAIDS
  • Malignancy within the last 5 years
  • GI disorders
To Learn more
Phase

4

Gender

Both Male and Female

Age

18 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

South Florida Medical Research
21150 Biscayne Blvd. #300
Aventura, FL 33180
Phone: 305-931-8080

View Map

Research Center Information: South Florida Medical Research

CW ID: 108337

Date Last Changed: July 25, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.